Clinical Trial: Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients

U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302464) titled 'Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients' on Dec. 11.

Brief Summary: The work aimed to compare the effects of Sodium-glucose co-transporter-2 (SGLT2) inhibitors on glomerular filtration rate (GFR) in patients with diabetic chronic kidney disease (CKD) and non-diabetic CKD.

Study Start Date: Oct. 01, 2024

Study Type: OBSERVATIONAL

Condition: Sodium Glucose Co-Transporter 2 Inhibitors Estimated Glomerular Filtration Rate Diabetes Chronic Kidney Disease

Intervention: OTHER: Sodium Glucose Co-Transporter 2 Inhibitors

All cand...